MAP3K5 and cervical carcinoma: Moreover, ASK1 silencing not only restored the metastatic potential of MTA2-knockdown cervical cancer cells (Fig. 4C) and MMP12 expression (Fig. 4D) but also diminished the activation of MEK3 and p38 in response to MTA2 knockdown (Fig. 4D).